ARCHIVES

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

This article is from The Cancer Letter archive.

Vol. 12 No. 14 | April 4, 1986

Download PDF Visit The Full Archive

Related Articles

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

NCI advisory Group, Other Cancer Meetings

March 29, 1985

Heart Institute Withdraws Sponsorship Of Breast Cancer Prevention Trial

October 27, 1995

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001